SAN DIEGO, Sept. 4, 2025 /PRNewswire/ — Aethlon Medical, Inc. (“Aethlon” or the “Company”) (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced the pricing of a public offering of an…
